Koo, H., Smith, T. B., Callaghan, J. T., Osei, W., Bray, S. M., Tillman, E. M., . . . Skaar, T. C. (2025). Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs. Wiley. https://doi.org/10.1002/cpt.3545
Chicago-Zitierstil (17. Ausg.)Koo, Hyunwoo, et al. Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs. Wiley, 2025. https://doi.org/10.1002/cpt.3545.
MLA-Zitierstil (9. Ausg.)Koo, Hyunwoo, et al. Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs. Wiley, 2025. https://doi.org/10.1002/cpt.3545.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.